AtCor Medical Pty Ltd

AtCor Medical develops and sells products for the early detection of target organ damage and the management of cardiovascular and renal diseases. Its technology allows researchers and clinicians to measure central arterial pressure waveforms, central aortic pressure, and pulse wave velocity in a non-invasive manner. The analysis of central arterial pressure waveforms measured by the company's SphygmoCor system provides clinicians with better prognostic and diagnostic information to determine the need and type of intervention, effects that cannot be detected through standard brachial blood pressure measurements.